Tariff Shock: Pharmaceutical stocks declined sharply by up to 5%


From October 1, the U.S. under Donald Trump will impose 100% tariffs on imported branded & patented medicines



Who’s exempt?

Only pharma firms that have begun setting up manufacturing plants in the U.S.


Immediate impact on Indian pharma stocks:

- Sun Pharma fell ~5%
- Biocon dropped 3.3%
- Lupin and Cipla slid ~2%



Overall, the Nifty Pharma index showed a reduction of 2.54%



Global outlook:

This move could squeeze margins for pharma exporters worldwide, while also reshaping investment decisions in the sector.


Source: Times Of India


What’s your take? Will this accelerate?